These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2873619)

  • 1. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
    Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
    Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluperlapine vs haloperidol: a comparison of their neuroendocrinological profiles and the influence on serum lipids.
    Fleischhacker WW; Stuppäck C; Moser C; Schubert H; Hinterhuber H
    Pharmacopsychiatry; 1986 May; 19(3):111-4. PubMed ID: 2873601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
    Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
    Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
    Mann K; Bartels M; Gärtner HJ; Schied HW; Wagner W; Heimann H
    Pharmacopsychiatry; 1987 Jul; 20(4):155-9. PubMed ID: 2886997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
    Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
    Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Three antipsychotic drugs in the treatment of schizophrenia--a controlled and double-blind study].
    Yang WJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):277-80, 318-9. PubMed ID: 3069383
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.
    Woggon B; Heinrich K; Küfferle B; Müller-Oerlinghausen B; Pöldinger W; Rüther E; Schied HW
    Arzneimittelforschung; 1984; 34(1A):122-4. PubMed ID: 6145427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic effects of verapamil in schizophrenia.
    Price WA
    Hillside J Clin Psychiatry; 1987; 9(2):225-30. PubMed ID: 3323023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine: double-blind control trial in the treatment of acute schizophrenia [proceedings].
    Shopsin B; Klein H; Aronson M
    Psychopharmacol Bull; 1978 Apr; 14(2):12-5. PubMed ID: 349596
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
    Daniel DG; Wozniak P; Mack RJ; McCarthy BG
    Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term double-blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia.
    Bechelli LP; Navas-Filho F
    Encephale; 1986; 12(3):121-5. PubMed ID: 2876879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
    Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
    Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
    [No Abstract]   [Full Text] [Related]  

  • 16. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind clinical study of HF 1854 (LX 100-129, clozapine or leponex) as compared with haloperidol].
    Ciurezu T; Ionescu R; Nica Udangiu S; Niţurad D; Oproiu L; Tudorache D; Popovici I; Curelaru S
    Neurol Psychiatr (Bucur); 1976; 14(1):29-34. PubMed ID: 788132
    [No Abstract]   [Full Text] [Related]  

  • 18. [Introductory words to the exchange of results on the clinical effects of bromperidol. Results of open and double blind research].
    Bures E; Pöldinger W
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():45-52. PubMed ID: 35479
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group.
    Awad AG; Lapierre YD; Angus C; Rylander A
    J Psychiatry Neurosci; 1997 Jul; 22(4):244-8. PubMed ID: 9262046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the clinical effects of bromperidol, a new butyrophenone derivative, and haloperidol on schizophrenia using a double-blind technique.
    Itoh H
    Psychopharmacol Bull; 1985; 21(1):120-2. PubMed ID: 3885289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.